These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37993281)

  • 41. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the disease.
    Lang MG; Vinagre CG; Bonfa E; Freitas FR; Pasoto SG; Brito TS; Seguro LP; Maranhão RC; Borba EF
    Lupus; 2022 May; 31(6):659-665. PubMed ID: 35332823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
    Garg S; Unnithan R; Hansen KE; Costedoat-Chalumeau N; Bartels CM
    Arthritis Care Res (Hoboken); 2021 May; 73(5):707-716. PubMed ID: 32004406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus.
    Yoshida M; Minowa K; Amano H; Asai Y; Yamaji K; Tamura N
    Lupus; 2021 Aug; 30(9):1378-1384. PubMed ID: 33966540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydroxychloroquine: a multifaceted treatment in lupus.
    Costedoat-Chalumeau N; Dunogué B; Morel N; Le Guern V; Guettrot-Imbert G
    Presse Med; 2014 Jun; 43(6 Pt 2):e167-80. PubMed ID: 24855048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood.
    Charlier B; Pingeon M; Dal Piaz F; Conti V; Valentini G; Filippelli A; Izzo V
    Biomed Chromatogr; 2018 Aug; 32(8):e4258. PubMed ID: 29669398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
    Takamasu E; Yokogawa N; Shimada K; Sugii S
    Lupus; 2019 Oct; 28(12):1473-1476. PubMed ID: 31575325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.
    Hanaoka H; Iida H; Kiyokawa T; Takakuwa Y; Kawahata K
    Intern Med; 2019 May; 58(9):1257-1262. PubMed ID: 30626831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
    Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
    JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine.
    Sakai R; Honda S; Tanaka E; Majima M; Konda N; Takada H; Harigai M
    Lupus; 2020 Nov; 29(13):1712-1718. PubMed ID: 32838624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus.
    Fasano S; Iudici M; Coscia MA; Messiniti V; Borgia A; Tirri R; Ciccia F
    Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35332100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia.
    Seo MR; Chae J; Kim YM; Cha HS; Choi SJ; Oh S; Roh CR
    Lupus; 2019 May; 28(6):722-730. PubMed ID: 30971164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
    Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers.
    Monzavi SM; Alirezaei A; Shariati-Sarabi Z; Tavakol Afshari J; Mahmoudi M; Dormanesh B; Jahandoost F; Khoshdel AR; Etemad Rezaie A
    Inflammopharmacology; 2018 Oct; 26(5):1175-1182. PubMed ID: 29987550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence.
    Osmani Z; Schrama TJ; Zacouris-Verweij W; Andersen J; Frankel S; Bultink IEM; Cornet A; van Vollenhoven RF
    Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33795484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.
    Schmajuk G; Yazdany J; Trupin L; Yelin E
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):386-92. PubMed ID: 20391485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of Initial Hydroxychloroquine Receipt Among Medicaid Beneficiaries With Incident Systemic Lupus Erythematosus.
    Pryor KP; Xu C; Collins JE; Costenbader KH; Feldman CH
    Arthritis Care Res (Hoboken); 2022 Aug; 74(8):1263-1268. PubMed ID: 33555101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus.
    Cornwell MG; Luttrell-Williams ES; Golpanian M; El Bannoudi H; Myndzar K; Izmirly P; Belmont HM; Katz S; Smilowitz NR; Engel A; Clancy R; Ruggles K; Buyon JP; Berger JS
    Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33737451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis.
    Andrade Balbi V; Artur Silva C; Nascimento Pedrosa T; Maria Rodrigues Pereira R; Maria de Arruda Campos L; Pires Leon E; Duarte N; Melechco Carvalho V; Gofinet Pasoto S; Cordeiro do Rosário D; Kolachinski Brandao L; I Brunner H; Bonfá E; Emi Aikawa N
    Lupus; 2022 Jan; 31(1):97-104. PubMed ID: 34965782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hydroxychloroquine Suppresses Interferon-inducible Genes and B Cell Activating Factor in Patients With Incomplete and New-onset Systemic Lupus Erythematosus.
    Lambers WM; Westra J; Bootsma H; de Leeuw K
    J Rheumatol; 2021 Jun; 48(6):847-851. PubMed ID: 33191279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adherence to hydroxychloroquine in patients with systemic lupus: Contrasting results and weak correlation between assessment tools.
    Hachulla E; Le Gouellec N; Launay D; Balquet MH; Maillard H; Azar R; Boldron A; Bataille P; Lambert M; Buchdahl AL; Allorge D; Hatron PY; Sobanski V; Hennart B; Clerson P; Morell-Dubois S;
    Joint Bone Spine; 2020 Dec; 87(6):603-610. PubMed ID: 32438061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.